Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study (Q33425338)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study |
scientific article |
Statements
1 reference
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study (English)
1 reference
Hagop Kantarjian
1 reference
Elias Jabbour
1 reference
David Rizzieri
1 reference
Naval Daver
1 reference
Gail Roboz
1 reference
Casey O'Connell
1 reference
Raoul Tibes
1 reference
Katherine Walsh
1 reference
Wendy Stock
1 reference
Mohammad Azab
1 reference
Woonbok Chung
1 reference
James N Lowder
1 reference
Karen Yee
1 reference
Elizabeth A Griffiths
1 reference
Sue Naim
1 reference
Pietro Taverna
1 reference
Aram Oganesian
1 reference
Yong Hao
1 reference
18 August 2015
1 reference
1 reference
16
1 reference
9
1 reference
1099-1110
1 reference
Identifiers
1 reference
1 reference
1 reference